| |
 |
 |
 Title: |
|
HIV/AIDS: Clinical Management and Treatment Protocols |
Code: |
OS0023-10 |
Date Active
5/4/2010 |
Date Inactive
6/30/2012 |
|
| Author(s): |
|
Rilla Taylor
Madeline F. Sawin
|
|
|
Course
Description: |
|
This HIV/AIDS course is designed for the health care professional who would like to learn more about the clinical management and current recommended treatment regimens of the patient that is HIV positive. HAART will be discussed, as well as treatment to control symptoms and to treat concurrent opportunistic and co-infections.
NOTE: This activity may be available in multiple formats or from different sponsors. ARRT regulations state that an individual may not repeat a self-learning activity for credit if it was reported in the same or any subsequent biennium. |
|
|
| Accreditors: |
|
ahra, CE Credits: 1, Category: A ARRT
DOH-BRC, CE Credits: 1, Category: 05 Personal Development
FL BD Athtrain, CE Credits: 1, Category: HIV/AIDS
FL BD CLS, CE Credits: 1, Category: HIVAIDS
FL BD EMS, CE Credits: 1, Category: HIV/AIDS REFRESHER TRAINING
FL BD LM, CE Credits: 1, Category: HIVAIDS
FL BD Massage, CE Credits: 1, Category: HIV/AIDS
FL BD Nurs, Contact Hours: 1, Category: HIV/AIDS
FL BD NursHmAdmin, CE Credits: 1, Category: HIV/AIDS
FL BD OrthPros, CE Credits: 1, Category: HIV/AIDS
FL BD PhysTher, CE Credits: 1, Category: HIV/AIDS
FL BD Podiatry, CE Credits: 1, Category: HIV/AIDS
FL BD RespCare, CE Credits: 1, Category: HIV/AIDS
FL CN MedPhys, CE Credits: 1, Category: HIV/AIDS
FL CN RD/N, CE Credits: 1, Category: HIV/AIDS
FL Elect CN, CE Credits: 1, Category: HIV/AIDS
FL OF SchoolPsych, CE Credits: 1, Category: GENERAL
|
 |
 |
|
Upon completion of this course, participants will be able to
1. describe the clinical management of the human immunodeficiency virus (HIV) infected patient;
2. name the various antiretroviral drug categories, their recommended treatment regimens, and the considerations and side effects of each;
3. define highly active antiretroviral therapy (HAART) and its preferred components, as well as identify therapy guidelines;
4. identify the prophylaxis medications used to prevent co-infections and opportunistic infections, and;
5. identify the common opportunistic and co-infections that may occur in the HIV positive person, and the treatment for each.
|
|
|
|
